Medi Tech Insights Logo.jpg
Global Digital Biomarkers Market is set to witness a significant CAGR of 35% from 2021 to 2026
May 16, 2022 09:30 ET | Medi-Tech Insights
Brussels, Belgium, May 16, 2022 (GLOBE NEWSWIRE) -- Description: Digital biomarkers are indexes that use data from digital platforms such as smartphones and wearable devices to objectively...
SBT_New August 2022 LOGO
Standard BioTools Announces First Quarter 2022 Financial Results
May 05, 2022 16:02 ET | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today...
Logo Blue Main.png
Neuronascent Releases Further Positive Results of NNI-362 in A Randomized Phase 1a Trial for Alzheimer’s Disease
March 30, 2022 06:00 ET | Neuronascent, Inc.
ROCKVILLE, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., is a clinical-stage pharmaceutical company discovering and developing novel regenerative therapies for age-related brain...
logo.jpg
Biomarkers In Cancer Targeted Immunotherapy
March 15, 2022 03:53 ET | KuicK Research
Delhi, March 15, 2022 (GLOBE NEWSWIRE) -- Global Breast Cancer Antibodies Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Breast Cancer Antibodies Market Opportunity:...
2020-0227 Cognition Logo for GNW.png
Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022
March 10, 2022 07:30 ET | Cognition Therapeutics, Inc.
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage neuroscience company developing drugs that treat age-related degenerative diseases of the...
LogoPressRelease.jpg
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 
February 17, 2022 17:43 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Inotiv_Logo_CMYK.png
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
January 04, 2022 08:33 ET | Inotiv, Inc.
-- Expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions -- -- Expected to enhance scale, broaden customer base...
LogoPressRelease.jpg
Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 16, 2021 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
C3i_Center larger res.png
C3i Center Inc. Secures CAP Accreditation, Launches New Lab Spinoff
November 09, 2021 10:00 ET | Centre C3i Inc.
MONTRÉAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- C3i Center Inc. has strengthened our position as Canada’s leading one-stop contract development and manufacturing organization operating in the cell...
LogoPressRelease.jpg
Fluidigm Announces Third Quarter 2021 Financial Results
November 08, 2021 16:02 ET | Fluidigm Corporation
Board Undertaking Review of Range of Value-Enhancing Opportunities SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology...